Original Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2009; 15(29): 3603-3610
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3603
Figure 2
Figure 2 Morphological changes in HepG2 cells after 48 h treatment with 12 &mgr;mol/L chelidonine (LD50) visualized by phase contrast microscopy. A: Apoptotic cells (black arrows) and a few cells undergoing blister cell death (white arrows) are clearly seen; B: Untreated control HepG2 cells.